Literature DB >> 591059

Effect of serum from various animal species on erythrocyte attachment of endotoxins and other bacterial antigens.

M Praino, E Neter.   

Abstract

Lipopolysaccharide O antigens (endotoxins) and other bacterial antigens readily attach to erythrocytes in vitro. This attachment is prevented by certain mammalian and avian sera. In this study, the inhibitory capacity of sera from lower animals was compared with that of higher animals for a total of 30 species. Antigens and the corresponding antisera included both crude O antigens and purified lipopolysaccharide preparations, the common enterobacterial antigen from Escherichia coli O14, the Vi antigen from Citrobacter ballerup, the polyribose-phosphate antigen from Haemophilus influenzae type b, and the crude teichoic acid antigen from Staphylococcus aureus. Antigen and serum mixtures were incubated at 37 degrees C for 30 min and used for erythrocyte modification; failure of hemagglutination by homologous bacterial antiserum provided evidence of inhibitory capacity. Sera from the classes Mammalia and Aves were very strong inhibitors; those of Reptilia and Osteichthyes were moderate in activity, displaying variation within the classes; those of Amphibia and Chondrichthyes were minimal inhibitors; and those of Merostomata, Crustacea, and Lamellibranchiata displayed questionable or no inhibitory capacity. Inhibitory sera were active with all antigens tested. The findings suggest evolution of inhibitory factors consistent with the theory of two diverging lines of animal phylogeny based on embryological criteria and closely parallel the observations of an endotoxin-altering capacity in vertebrate sera that is not found in invertebrate sera or hemolymph.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591059      PMCID: PMC421279          DOI: 10.1128/iai.18.3.612-616.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Studies of enterobacterial lipopolysaccharides; effects of heat and chemicals on erythrocyte-modifying, antigenic, toxic and pyrogenic properties.

Authors:  E NETER; O WESTPHAL; O LUDERITZ; E A GORZYNSKI; E EICHENBERGER
Journal:  J Immunol       Date:  1956-05       Impact factor: 5.422

2.  Bacterial hemagglutination and hemolysis.

Authors:  E NETER
Journal:  Bacteriol Rev       Date:  1956-09

3.  The bacterial hemagglutination test for the demonstration of antibodies to Enterobacteriaceae.

Authors:  E A GORZYNSKI; O LUDERITZ; E NETER; O WESTPHAL
Journal:  Ann N Y Acad Sci       Date:  1956-08-10       Impact factor: 5.691

4.  Inhibition of bacterial (Escherichia coli) modification of erythrocytes.

Authors:  E NETER; D A ZAK; N J ZALEWSKI; L F BERTRAM
Journal:  Proc Soc Exp Biol Med       Date:  1952 Aug-Sep

5.  The inactivation of endotoxin after interaction with certain proteins of normal serum.

Authors:  R C Skarnes
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

6.  Specificity of an erythrocyte membrane receptor for bacterial antigens.

Authors:  H Y Whang; E Neter; G F Springer
Journal:  Z Immunitatsforsch Allerg Klin Immunol       Date:  1970

7.  Inactivation of endotoxin by serum: a phylogenetic study.

Authors:  K B Von Eschen; J A Rudbach
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

8.  The requirement for serum complement in the detoxification of bacterial endotoxin.

Authors:  K J Johnson; P A Ward
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

9.  Endotoxin-binding substances from human leukocytes and platelets.

Authors:  G F Springer; J C Adye
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

10.  Host defense against bacterial endotoxemia: mechanism in normal animals.

Authors:  R C Skarnes
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  1 in total

1.  The binding of immune complexes to human red cells: complement requirements and fate of the RBC-bound IC after interaction with human phagocytic cells.

Authors:  T A Sherwood; G Virella
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.